Isavuconazole Treatment of Cryptococcosis and Dimorphic Mycoses.
about
Isavuconazole for the treatment of invasive aspergillosis and mucormycosis: current evidence, safety, efficacy, and clinical recommendationsIntegrated therapy for HIV and cryptococcosisIn Vitro Activity of Isavuconazole against Rasamsonia SpeciesTreatment considerations in pulmonary coccidioidomycosis.Intrathecal Amphotericin B: A 60-Year Experience in Treating Coccidioidal Meningitis.Molecular characterisation and antifungal susceptibility of clinical Cryptococcus deuterogattii (AFLP6/VGII) isolates from Southern Brazil.Histoplasmosis in transplant recipients.Opportunistic Invasive Mycoses in AIDS: Cryptococcosis, Histoplasmosis, Coccidiodomycosis, and Talaromycosis.New pharmacological opportunities for the treatment of invasive mould diseases.Isavuconazole: is there a need for a new antifungal?Isavuconazole Is Effective for the Treatment of Experimental Cryptococcal Meningitis.Tissue Distribution and Elimination of Isavuconazole following Single and Repeat Oral-Dose Administration of Isavuconazonium Sulfate to Rats.In vitro activity of isavuconazole against fluconazole-resistant isolates of Histoplasma capsulatum.A Review of the Clinical Pharmacokinetics and Pharmacodynamics of Isavuconazole.Spotlight on isavuconazole in the treatment of invasive aspergillosis and mucormycosis: design, development, and place in therapy.The war on cryptococcosis: A Review of the antifungal arsenal.Severe acute respiratory distress syndrome in a liver transplant patient.Present and Future Therapy of Infections
P2860
Q28067726-9DB9D56D-2155-46A7-8DF9-50EB06A80D7AQ28077707-C23F6C64-41D5-45E1-8C64-D6B2DAAF9C8EQ36104417-9727BEFB-124F-4FC4-BFDF-07D973BF106EQ38820536-08DBF1DA-7906-4D70-BF99-A9B607F33335Q39032299-2508EBFC-EA7D-4A8F-BFC8-001856F40F83Q39064815-DEC0C7E4-E17A-4F00-8CBA-7EA92638CA38Q40043530-1F000B28-1248-4F32-BC98-CE74E4016291Q40074359-04194863-4DDA-4CAE-AE34-2F69BAECEC2EQ40273481-618D73D1-7F0F-4B64-90B6-16E92BCE4D98Q40273512-B2D17FD7-C6B3-40FB-A033-C527806DB3F2Q41188300-D3F7C179-86AA-4831-A04E-1BEE7BB0826EQ47151374-69602F1D-1D0C-46F9-813A-A57BE92B1F45Q47290283-D987D29F-B4CF-47F5-B0A3-C40077AFA965Q47660181-546DDE2C-53E6-40E5-A450-080D4E28DA5AQ54214603-64744139-F325-40C5-90B6-59EFD43FE509Q54260674-3EF7683D-988A-4495-8331-698A5B66A21EQ55426749-84E19BAC-CDF2-4C50-B43B-EC3C3D7D8A04Q57177336-189073B2-A467-433D-9077-FDE893CA0373
P2860
Isavuconazole Treatment of Cryptococcosis and Dimorphic Mycoses.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 11 May 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Isavuconazole Treatment of Cryptococcosis and Dimorphic Mycoses.
@en
Isavuconazole Treatment of Cryptococcosis and Dimorphic Mycoses.
@nl
type
label
Isavuconazole Treatment of Cryptococcosis and Dimorphic Mycoses.
@en
Isavuconazole Treatment of Cryptococcosis and Dimorphic Mycoses.
@nl
prefLabel
Isavuconazole Treatment of Cryptococcosis and Dimorphic Mycoses.
@en
Isavuconazole Treatment of Cryptococcosis and Dimorphic Mycoses.
@nl
P2093
P2860
P356
P1476
Isavuconazole Treatment of Cryptococcosis and Dimorphic Mycoses.
@en
P2093
Adrian Rendon
Flavio Queiroz-Telles
George R Thompson
Jose A Vazquez
Laura Kovanda
Luis Ostrosky-Zeichner
Marc Engelhardt
Nkechi Azie
Oliver A Cornely
P2860
P304
P356
10.1093/CID/CIW305
P407
P577
2016-05-11T00:00:00Z